US Patent Issued to SIGILON THERAPEUTICS on April 21 for "Afibrotic compounds, devices, and uses thereof" (Massachusetts, Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,486, issued on April 21, was assigned to SIGILON THERAPEUTICS INC. (Cambridge, Mass.).

"Afibrotic compounds, devices, and uses thereof" was invented by Richard Heidebrecht (Somerville, Mass.), Robert James Miller (East Bridgewater, Mass.) and Omid Veiseh (Bellaire, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds of Formula (I), modified polymers and implantable elements comprising compounds of Formula (II), as well as compositions and methods of use thereof. In particular, the compounds, modified polymers, implantable elements and related compositions may be used in methods for the prevention and treatment of a d...